ClearBridge Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$138M Sell
1,088,957
-142,193
-12% -$18.7M 0.11% 179
2026
Q1
$172M Buy
1,231,150
+9,458
+0.8% +$1.32M 0.15% 145
2025
Q4
$150M Sell
1,221,692
-51,395
-4% -$6.25M 0.12% 180
2025
Q3
$141M Sell
1,273,087
-35,380
-3% -$4.02M 0.11% 189
2025
Q2
$145M Sell
1,308,467
-744,106
-36% -$79.2M 0.12% 171
2025
Q1
$230M Sell
2,052,573
-1,921,225
-48% -$198M 0.2% 121
2024
Q4
$367M Sell
3,973,798
-1,202,502
-23% -$108M 0.3% 91
2024
Q3
$434M Buy
5,176,300
+395,269
+8% +$30.2M 0.34% 77
2024
Q2
$328M Sell
4,781,031
-56,526
-1% -$3.77M 0.27% 94
2024
Q1
$354M Sell
4,837,557
-84,104
-2% -$6.47M 0.28% 95
2023
Q4
$399M Buy
4,921,661
+377,676
+8% +$29.4M 0.34% 75
2023
Q3
$341M Buy
4,543,985
+2,915,141
+179% +$224M 0.33% 85
2023
Q2
$126M Buy
1,628,844
+442,972
+37% +$35.3M 0.11% 184
2023
Q1
$98.4M Sell
1,185,872
-6,511
-0.5% -$539K 0.09% 207
2022
Q4
$102M Sell
1,192,383
-330,741
-22% -$26.2M 0.1% 201
2022
Q3
$94M Buy
1,523,124
+93,668
+7% +$5.91M 0.09% 205
2022
Q2
$88.4M Sell
1,429,456
-64,241
-4% -$3.98M 0.08% 225
2022
Q1
$88.8M Sell
1,493,697
-537,540
-26% -$34.4M 0.07% 265
2021
Q4
$147M Buy
2,031,237
+68,690
+4% +$4.73M 0.1% 189
2021
Q3
$137M Buy
1,962,547
+142,453
+8% +$10M 0.1% 198
2021
Q2
$125M Buy
1,820,094
+105,482
+6% +$7.04M 0.09% 204
2021
Q1
$111M Buy
1,714,612
+1,028,302
+150% +$66.3M 0.08% 205
2020
Q4
$40M Buy
686,310
+185,217
+37% +$11.2M 0.03% 363
2020
Q3
$31.7M Buy
501,093
+361,100
+258% +$25M 0.03% 350
2020
Q2
$10.8M Sell
139,993
-37,133
-21% -$2.85M 0.01% 502
2020
Q1
$13.2M Sell
177,126
-597,246
-77% -$41.3M 0.01% 431
2019
Q4
$50.5M Sell
774,372
-15,502
-2% -$1.01M 0.04% 326
2019
Q3
$50.1M Sell
789,874
-12,728
-2% -$832K 0.04% 314
2019
Q2
$54.2M Sell
802,602
-14,952
-2% -$984K 0.05% 305
2019
Q1
$53.1M Sell
817,554
-748
-0.1% -$49.7K 0.05% 301
2018
Q4
$51.2M Buy
818,302
+533,033
+187% +$37.3M 0.05% 290
2018
Q3
$22M Sell
285,269
-118,919
-29% -$8.98M 0.02% 428
2018
Q2
$28.6M Buy
404,188
+326,552
+421% +$23.1M 0.02% 380
2018
Q1
$5.85M Buy
77,636
+64,124
+475% +$5.1M 0.01% 500
2017
Q4
$968K Buy
13,512
+12,842
+1,917% +$975K ﹤0.01% 643
2017
Q3
$54K Sell
670
-150
-18% -$11.5K ﹤0.01% 836
2017
Q2
$58K Sell
820
-1,327
-62% -$88.3K ﹤0.01% 830
2017
Q1
$146K Sell
2,147
-283
-12% -$19.9K ﹤0.01% 786
2016
Q4
$174K Sell
2,430
-56
-2% -$4.16K ﹤0.01% 797
2016
Q3
$197K Sell
2,486
-112
-4% -$9.1K ﹤0.01% 774
2016
Q2
$217K Sell
2,598
-50
-2% -$4.44K ﹤0.01% 770
2016
Q1
$243K Sell
2,648
-369
-12% -$33.3K ﹤0.01% 772
2015
Q4
$305K Buy
3,017
+270
+10% +$28.1K ﹤0.01% 799
2015
Q3
$270K Buy
2,747
+794
+41% +$88.2K ﹤0.01% 840
2015
Q2
$229K Buy
1,953
+444
+29% +$48.5K ﹤0.01% 839
2015
Q1
$148K Sell
1,509
-408
-21% -$41.4K ﹤0.01% 878
2014
Q4
$181K Buy
1,917
+1,016
+113% +$105K ﹤0.01% 875
2014
Q3
$96K Sell
901
-233
-21% -$22.8K ﹤0.01% 910
2014
Q2
$94K Sell
1,134
-755
-40% -$58.8K ﹤0.01% 898
2014
Q1
$134K Buy
1,889
+583
+45% +$45.7K ﹤0.01% 869
2013
Q4
$98K Sell
1,306
-666
-34% -$46.4K ﹤0.01% 879
2013
Q3
$124K Buy
1,972
+1,049
+114% +$62.7K ﹤0.01% 841
2013
Q2
$48K Buy
+923
New +$48.1K ﹤0.01% 897

Other funds holding GILD

ClearBridge Investments's GILD Position: Q2 2026 in Review

ClearBridge Investments reduced its Gilead Sciences (GILD) stake by 12% in Q2 2026, selling an estimated $18.7M and leaving 1,088,957 shares worth $138M. The position accounts for 0.11% of the portfolio, ranked #179.

ClearBridge Investments first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $434M in Q3 2024. 1,917 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • ClearBridge Investments held 1,088,957 shares of Gilead Sciences worth $138M as of Q2 2026.
  • ClearBridge Investments sold 142,193 Gilead Sciences shares in Q2 2026, an estimated $18.7M.
  • Gilead Sciences made up 0.11% of ClearBridge Investments's portfolio in Q2 2026, its #179 holding.
  • ClearBridge Investments first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • ClearBridge Investments's Gilead Sciences position peaked at $434M in Q3 2024.
  • 1,917 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.